BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 33678036)

  • 1. Early intervention with probiotics and metformin alleviates liver injury in NAFLD rats via targeting gut microbiota dysbiosis and p-AKT/mTOR/LC-3II pathways.
    Seif El-Din SH; Salem MB; El-Lakkany NM; Hammam OA; Nasr SM; Okasha H; Ahmed LA; Saleh S; Botros SS
    Hum Exp Toxicol; 2021 Sep; 40(9):1496-1509. PubMed ID: 33678036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota modulation as a promising therapy with metformin in rats with non-alcoholic steatohepatitis: Role of LPS/TLR4 and autophagy pathways.
    Ahmed LA; Salem MB; Seif El-Din SH; El-Lakkany NM; Ahmed HO; Nasr SM; Hammam OA; Botros SS; Saleh S
    Eur J Pharmacol; 2020 Nov; 887():173461. PubMed ID: 32758573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin ameliorates maternal high-fat diet-induced maternal dysbiosis and fetal liver apoptosis.
    Huang SW; Ou YC; Tang KS; Yu HR; Huang LT; Tain YL; Lin IC; Sheen JM; Hou CY; Tsai CC; Tiao MM
    Lipids Health Dis; 2021 Sep; 20(1):100. PubMed ID: 34496884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactobacillus reuteri DSM 17938 alleviates d-galactosamine-induced liver failure in rats.
    Jiang H; Yan R; Wang K; Wang Q; Chen X; Chen L; Li L; Lv L
    Biomed Pharmacother; 2021 Jan; 133():111000. PubMed ID: 33202285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Administration of Compound Probiotics Ameliorates HFD-Induced Gut Microbe Dysbiosis and Chronic Metabolic Inflammation via the G Protein-Coupled Receptor 43 in Non-alcoholic Fatty Liver Disease Rats.
    Liang Y; Liang S; Zhang Y; Deng Y; He Y; Chen Y; Liu C; Lin C; Yang Q
    Probiotics Antimicrob Proteins; 2019 Mar; 11(1):175-185. PubMed ID: 29353414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats.
    Shen SH; Zhong TY; Peng C; Fang J; Lv B
    BMC Complement Med Ther; 2020 Feb; 20(1):34. PubMed ID: 32024509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Maternal Gut Microbiota-Targeted Therapy on the Programming of Nonalcoholic Fatty Liver Disease in Dams and Fetuses, Related to a Prenatal High-Fat Diet.
    Yu HR; Sheen JM; Hou CY; Lin IC; Huang LT; Tain YL; Cheng HH; Lai YJ; Lin YJ; Tiao MM; Tsai CC
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of Probiotics and
    Wang W; Xu AL; Li ZC; Li Y; Xu SF; Sang HC; Zhi F
    Diabetes Metab J; 2020 Apr; 44(2):336-348. PubMed ID: 31950772
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Liu T; Zhou L; Li X; Song W; Liu Y; Wu S; Wang P; Dai X; Shi L
    J Agric Food Chem; 2024 May; 72(17):9880-9892. PubMed ID: 38646869
    [No Abstract]   [Full Text] [Related]  

  • 11. Selenium-Enriched Probiotic Alleviates Western Diet-Induced Non-alcoholic Fatty Liver Disease in Rats via Modulation of Autophagy Through AMPK/SIRT-1 Pathway.
    Pant R; Sharma N; Kabeer SW; Sharma S; Tikoo K
    Biol Trace Elem Res; 2023 Mar; 201(3):1344-1357. PubMed ID: 35499800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretion of Recombinant Interleukin-22 by Engineered Lactobacillus reuteri Reduces Fatty Liver Disease in a Mouse Model of Diet-Induced Obesity.
    Oh JH; Schueler KL; Stapleton DS; Alexander LM; Yen CE; Keller MP; Attie AD; van Pijkeren JP
    mSphere; 2020 Jun; 5(3):. PubMed ID: 32581074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perilla Seed Oil Alleviates Gut Dysbiosis, Intestinal Inflammation and Metabolic Disturbance in Obese-Insulin-Resistant Rats.
    Kangwan N; Pratchayasakul W; Kongkaew A; Pintha K; Chattipakorn N; Chattipakorn SC
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective Role of Probiotic Supplements in Hepatic Steatosis: A Rat Model Study.
    Azarang A; Farshad O; Ommati MM; Jamshidzadeh A; Heydari R; Abootalebi SN; Gholami A
    Biomed Res Int; 2020; 2020():5487659. PubMed ID: 33299871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotics Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats via Gut Microbiota/FXR/FGF15 Signaling Pathway.
    Luo M; Yan J; Wu L; Wu J; Chen Z; Jiang J; Chen Z; He B
    J Immunol Res; 2021; 2021():2264737. PubMed ID: 34458376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
    Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
    mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Probiotics (MCP
    Mohamad Nor MH; Ayob N; Mokhtar NM; Raja Ali RA; Tan GC; Wong Z; Shafiee NH; Wong YP; Mustangin M; Nawawi KNM
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?
    Xie C; Halegoua-DeMarzio D
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31752378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats.
    Zhang Y; Tang K; Deng Y; Chen R; Liang S; Xie H; He Y; Chen Y; Yang Q
    Biomed Pharmacother; 2018 Jun; 102():1025-1036. PubMed ID: 29710519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Combination of Berberine, Tocotrienols and Coffee Extracts Improves Metabolic Profile and Liver Steatosis by the Modulation of Gut Microbiota and Hepatic miR-122 and miR-34a Expression in Mice.
    Cossiga V; Lembo V; Nigro C; Mirra P; Miele C; D'Argenio V; Leone A; Mazzone G; Veneruso I; Guido M; Beguinot F; Caporaso N; Morisco F
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33924725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.